ALDH1A1 and triple-negative breast carcinoma: From the statistical analysis of the data, ALDH1 can be used as a prognostic factor of poor survival in triple-negative breast cancer patients with a hazard ratio of 2.636 with a p value of 0.013 although it cannot be an independent prognostic factor.